What is the official ID of this bill?

The official print number for this legislation is HR 1463.

When did the legislative process begin?

The process officially started on 2025-02-21.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/119/bills/hr1463/BILLS-119hr1463ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

Who is the primary sponsor?

The primary sponsor is Rep. Finstad, Brad [R-MN-1].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Analysis and Potential Impact of HR 1463

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Prohibition on Federal Funding for FDA Laboratory Developed Tests Rule

Q: What are the main provisions?

Key points include: Funding Ban: The bill prohibits the use of Federal funds to implement, administer, or enforce the FDA final rule regarding Laboratory Developed Tests (LDTs). Specific Rule Target: The prohibition specifically targets the rule submitted for publication in the Federal Register on May 6, 2024 (89 Fed. Reg. 37286). Substantially Similar Rules: The restriction on funding also extends to any rule that is substantially similar to the specified FDA rule.

This bill prohibits the use of Federal funds to implement, administer, or enforce the final rule of the Food and Drug Administration relating to “Medical Devices; Laboratory Developed Tests” submitted for publication on May 6, 2024. The prohibition also applies to any substantially similar rule.

Key points

Funding Ban: The bill prohibits the use of Federal funds to implement, administer, or enforce the FDA final rule regarding Laboratory Developed Tests (LDTs).

Specific Rule Target: The prohibition specifically targets the rule submitted for publication in the Federal Register on May 6, 2024 (89 Fed. Reg. 37286).

Substantially Similar Rules: The restriction on funding also extends to any rule that is substantially similar to the specified FDA rule.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Introduced

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes.

Print number: HR 1463

Sponsor: Rep. Finstad, Brad [R-MN-1]

Process start date: 2025-02-21

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-3-pro-preview

Source data: api.congress.gov

AI work logs for this document launch